Influenza prevention

Last updated

Influenza prevention involves taking steps that one can use to decrease their chances of contracting flu viruses, such as the Pandemic H1N1/09 virus, responsible for the 2009 flu pandemic.

Contents

Transmission

Sneezing can transmit influenza. Sneeze.JPG
Sneezing can transmit influenza.

People who contract influenza are most infective between the second and third days after infection, and infectivity lasts for around ten days. [1] Children are much more infectious than adults and shed virus from just before they develop symptoms until two weeks after infection. [1] [2] The transmission of influenza can be modeled mathematically, which helps predict how the virus will spread in a population. [3]

Influenza can be spread in three main ways: [4] [5]

The relative importance of these three modes of transmission is unclear, and they may all contribute to the spread of the virus. [7] [8] In the airborne route, the droplets that are small enough for people to inhale are 0.5 to 5  µm in diameter and inhaling just one droplet might be enough to cause an infection. [4] Although a single sneeze releases up to 40,000 droplets, [9] most of these droplets are quite large and will quickly settle out of the air. [4] How long influenza survives in airborne droplets seems to be influenced by the levels of humidity and UV radiation: with low humidity and a lack of sunlight in winter probably aiding its survival. [4]

As the influenza virus can persist outside of the body, it can also be transmitted by contaminated surfaces such as banknotes, [10] doorknobs, light switches and other household items. [11] The length of time the virus will persist on a surface varies, with the virus surviving for one to two days on hard, non-porous surfaces such as plastic or metal, for about fifteen minutes from dry paper tissues, and only five minutes on skin. [12] However, if the virus is present in mucus, this can protect it for longer periods. [4] Avian influenza viruses can survive indefinitely when frozen. [13] They are inactivated by heating to 56 °C (133 °F) for a minimum of 60 minutes, as well as by acids (at pH <2). [13]

Novel H1N1

According to the World Health Organization (WHO), the "main route of transmission of the pandemic influenza virus seems to be similar to seasonal influenza, via droplets that are expelled by speaking, sneezing or coughing." [14] One of WHO's recommendations is to "keep your distance from people who show symptoms of influenza-like illness, such as coughing and sneezing (trying to maintain a distance of about 1 metre if possible)." [14] Other WHO recommendations are listed below.

The American Centers for Disease Control and Prevention (CDC) agrees that the "spread of novel H1N1 virus is thought to occur in the same way that seasonal flu spreads. Flu viruses are spread mainly from person to person through coughing or sneezing by people with influenza." [6] The CDC also says that a person may become infected if he or she touches something with flu viruses on it "and then touches his or her eyes, nose, or mouth." [6]

Researchers have demonstrated anti-bodies against H1N1 variant influenza in 10 to 7 percent of workers and residents of swine farms in Jiangsu Province, China. Residents of a nearby city did not have detectable anti-bodies to H1N1 variant influenza. [15]

Prevention

Reasonably effective ways to reduce the transmission of influenza include good personal health and hygiene habits such as: not touching your eyes, nose or mouth; [6] frequent hand washing (with soap and water, or with alcohol-based hand rubs); [6] covering coughs and sneezes; avoiding close contact with sick people; and staying home yourself if you are sick. Avoiding spitting is also recommended. [16]

Although face masks might help prevent transmission when caring for the sick, [17] [18] there is mixed evidence on beneficial effects in the community. [16] [19] Smoking raises the risk of contracting influenza, as well as producing more severe disease symptoms. [20] [21] [22] [23] [24] Thus, according to the laws of mathematical modelling of infectious diseases, smokers raise the exponential growth rates of influenza epidemics and may indirectly be responsible for a large percentage of influenza cases.[ citation needed ]

Since influenza spreads through both aerosols and contact with contaminated surfaces, surface sanitizing may help prevent some infections. [25] Alcohol is an effective sanitizer against influenza viruses, while quaternary ammonium compounds can be used with alcohol so that the sanitizing effect lasts for longer. [26] In hospitals, quaternary ammonium compounds and bleach are used to sanitize rooms or equipment that have been occupied by patients with influenza symptoms. [26] At home, this can be done effectively with a diluted chlorine bleach. [27]

Social distancing strategies used during past pandemics, such as closing schools, churches and theaters, slowed the spread of the virus but did not have a large effect on the overall death rate. [28] [29] It is uncertain if reducing public gatherings, by for example closing schools and workplaces, will reduce transmission since people with influenza may just be moved from one area to another; such measures would also be difficult to enforce and might be unpopular. [16] When small numbers of people are infected, isolating the sick might reduce the risk of transmission. [16]

According to studies conducted in Australia and Japan, screening individuals for influenza symptoms at airports during the 2009 H1N1 outbreak was not an effective method of infection control. [30] [31]

Workplace

The Centers for Disease Control and Prevention (CDCP) recommends that businesses promote and administer annual flu vaccination within the workplace. Additional measures include reducing potential for exposure through increasing awareness of flu symptoms, using good cough and sneeze etiquette, staying home when ill, and frequent hand washing. [32]

The Occupational Health and Safety Administration (OSHA) recommends these controls to employers to decrease transmission of influenza in the workplace: [33]

Specific occupations with increased risk of influenza infection include health care, education and child care, air line industry, and agricultural workers.

WHO recommendations

According to the WHO, you can decrease your chance of contracting the flu virus by taking the following steps: [14]

CDCP recommendations

The CDCP lists these as important ways to lower the risk of transmission: [6]

Children

Watch for emergency warning signs that need urgent medical attention. These warning signs include:[ citation needed ]

Vaccination against H1N1

In the 2009 pandemic, the initial demand for vaccine greatly outstripped the supply. [35]

2,500 people line up in a mall in Texas City, Texas to receive the H1N1 vaccine from the Galveston County Health Department. 2009 H1N1 Swine Flu Line.jpg
2,500 people line up in a mall in Texas City, Texas to receive the H1N1 vaccine from the Galveston County Health Department.

As the 2009 pandemic got underway, the first vaccine to become available in the United States by mid-October 2009 was about 2.2 million doses of the weakened live-virus nasal spray formulation. This form was not then recommended for some of the people who were at highest risk of complications from flu, including pregnant women and people with asthma.[ citation needed ] The attenuated live virus was instead suggested to be used to allow some priority groups like health care workers and healthy children 2 or older, to allow them to be vaccinated immediately. Those to whom the weakened virus might pose a heightened risk were recommended to wait for the release of killed-virus vaccines, which followed weeks to months later.[ citation needed ]

Vaccine uptake by the public was very low in the UK, but predicted by greater belief in the vaccine's efficacy and safety and a greater perceived risk of the disease. [36]

Public opinion

A survey of Americans done in late June 2009 by the Harvard School of Public Health found that roughly 90% said they would be willing to avoid shopping malls, movie theaters, public transportation, and worship services for more than two weeks if health officials told them to. It also found that parents were worried about closures of schools or day care centers, with 43% saying they would lose pay or have money problems if they had to stay home a week or more because they were sick or had to care for someone. [37] [38] In the UK, the government established a National Pandemic Flu Service with a hotline and website, enabling persons with symptoms to get advice or obtain drugs without first getting a prescription from a doctor. [39]

Increased risk of transmission for agriculture workers

Individuals with increased exposure to animals, especially birds and swine, are at increased risk of variant influenza infection. This includes agricultural workers, as well as residents of farms, individuals who keep swine and/or birds as pets, and animal exhibitors. Variant influenza viruses do not normally infect humans, but when they do cause human infection, the virus can be passed from animals to humans directly, or between humans. [40] Due to human to human transmission, family and close contacts of agricultural workers are at increased risk of influenza as well. Unfortunately, there is also decreased access to health care in agricultural communities which makes prevention and response to influenza outbreaks more difficult. [41] During the 2009 H1N1 pandemic, multiple factors were identified as increasing the vulnerability of agricultural workers and their communities. These factors included substandard housing, immigration status, scape-goating, economic barriers, communication and cultural barriers, and discrimination. [41] [42] Steege et al., found that 75% of agricultural workers were uninsured, making them less likely to receive the flu vaccine and less likely to seek care when ill. [42]

Public health recommendations for agricultural communities: [42]

Recommendations for agricultural workers and exhibitors: [43]

Additional recommendations for visitors to agricultural exhibits: [15]

See also

Related Research Articles

<i>Influenza A virus</i> Species of virus

Influenza A virus (IAV) is a pathogen that causes the flu in birds and some mammals, including humans. It is an RNA virus whose subtypes have been isolated from wild birds. Occasionally, it is transmitted from wild to domestic birds, and this may cause severe disease, outbreaks, or human influenza pandemics.

<i>Orthomyxoviridae</i> Family of RNA viruses including the influenza viruses

Orthomyxoviridae is a family of negative-sense RNA viruses. It includes seven genera: Alphainfluenzavirus, Betainfluenzavirus, Gammainfluenzavirus, Deltainfluenzavirus, Isavirus, Thogotovirus, and Quaranjavirus. The first four genera contain viruses that cause influenza in birds and mammals, including humans. Isaviruses infect salmon; the thogotoviruses are arboviruses, infecting vertebrates and invertebrates. The Quaranjaviruses are also arboviruses, infecting vertebrates (birds) and invertebrates (arthropods).

<span class="mw-page-title-main">Oseltamivir</span> Antiviral medication used against influenza A and influenza B

Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B, viruses that cause the flu. Many medical organizations recommend it in people who have complications or are at high risk of complications within 48 hours of first symptoms of infection. They recommend it to prevent infection in those at high risk, but not the general population. The Centers for Disease Control and Prevention (CDC) recommends that clinicians use their discretion to treat those at lower risk who present within 48 hours of first symptoms of infection. It is taken by mouth, either as a pill or liquid.

<span class="mw-page-title-main">Influenza vaccine</span> Vaccine against influenza

Influenza vaccines, colloquially known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed twice a year, as the influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. Vaccination against influenza began in the 1930s, with large-scale availability in the United States beginning in 1945.

<span class="mw-page-title-main">Agricultural show</span> Public event exhibiting agriculture equipment

An agricultural show is a public event exhibiting the equipment, animals, sports and recreation associated with agriculture and animal husbandry. The largest comprise a livestock show, a trade fair, competitions, and entertainment. The work and practices of farmers, animal fanciers, cowboys, and zoologists may be displayed. The terms agricultural show and livestock show are synonymous with the North American terms county fair and state fair.

<span class="mw-page-title-main">Swine influenza</span> Infection caused by influenza viruses endemic to pigs

Swine influenza is an infection caused by any of several types of swine influenza viruses. Swine influenza virus (SIV) or swine-origin influenza virus (S-OIV) refers to any strain of the influenza family of viruses that is endemic in pigs. As of 2009, identified SIV strains include influenza C and the subtypes of influenza A known as H1N1, H1N2, H2N1, H3N1, H3N2, and H2N3.

<span class="mw-page-title-main">Flu season</span> Recurring periods of influenza

Flu season is an annually recurring time period characterized by the prevalence of an outbreak of influenza (flu). The season occurs during the cold half of the year in each hemisphere. It takes approximately two days to show symptoms. Influenza activity can sometimes be predicted and even tracked geographically. While the beginning of major flu activity in each season varies by location, in any specific location these minor epidemics usually take about three weeks to reach its pinnacle, and another three weeks to significantly diminish.

<span class="mw-page-title-main">Influenza A virus subtype H1N1</span> Subtype of Influenza A virus

In virology, influenza A virus subtype H1N1 (A/H1N1) is a subtype of influenza A virus. Major outbreaks of H1N1 strains in humans include the 1918 Spanish flu pandemic, the 1977 Russian flu pandemic and the 2009 swine flu pandemic. It is an orthomyxovirus that contains the glycoproteins hemagglutinin (H) and neuraminidase (N), antigens whose subtypes are used to classify the strains of the virus as H1N1, H1N2 etc. Hemagglutinin causes red blood cells to clump together and binds the virus to the infected cell. Neuraminidase is a type of glycoside hydrolase enzyme which helps to move the virus particles through the infected cell and assist in budding from the host cells.

<span class="mw-page-title-main">Influenza pandemic</span> Pandemic involving influenza

An influenza pandemic is an epidemic of an influenza virus that spreads across a large region and infects a large proportion of the population. There have been six major influenza epidemics in the last 140 years, with the 1918 flu pandemic being the most severe; this is estimated to have been responsible for the deaths of 50–100 million people. The 2009 swine flu pandemic resulted in under 300,000 deaths and is considered relatively mild. These pandemics occur irregularly.

<span class="mw-page-title-main">Influenza A virus subtype H3N2</span> Virus subtype

Influenza A virus subtype H3N2 (A/H3N2) is a subtype of viruses that causes influenza (flu). H3N2 viruses can infect birds and mammals. In birds, humans, and pigs, the virus has mutated into many strains. In years in which H3N2 is the predominant strain, there are more hospitalizations.

<span class="mw-page-title-main">Canine influenza</span>

Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.

<span class="mw-page-title-main">Pandemrix</span> Flu vaccine

Pandemrix is an influenza vaccine for influenza pandemics, such as the 2009 flu pandemic. The vaccine was developed by GlaxoSmithKline (GSK) and patented in September 2006.

<span class="mw-page-title-main">Influenza</span> Infectious disease

Influenza, commonly known as "the flu" or just "flu", is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin from one to four days after exposure to the virus and last for about 2–8 days. Diarrhea and vomiting can occur, particularly in children. Influenza may progress to pneumonia, which can be caused by the virus or by a subsequent bacterial infection. Other complications of infection include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.

<span class="mw-page-title-main">Influenza-like illness</span> Medical diagnosis

Influenza-like illness (ILI), also known as flu-like syndrome or flu-like symptoms, is a medical diagnosis of possible influenza or other illness causing a set of common symptoms. These include fever, shivering, chills, malaise, dry cough, loss of appetite, body aches, nausea, and sneezing typically in connection with a sudden onset of illness. In most cases, the symptoms are caused by cytokines released by immune system activation, and are thus relatively non-specific.

<span class="mw-page-title-main">2009 swine flu pandemic</span> 2009–2010 pandemic of swine influenza caused by H1N1 influenza virus

The 2009 swine flu pandemic, caused by the H1N1/swine flu/influenza virus and declared by the World Health Organization (WHO) from June 2009 to August 2010, was the third recent flu pandemic involving the H1N1 virus. The first identified human case was in La Gloria, Mexico, a rural town in Veracruz. The virus appeared to be a new strain of H1N1 that resulted from a previous triple reassortment of bird, swine, and human flu viruses which further combined with a Eurasian pig flu virus, leading to the term "swine flu".

The 2009 flu pandemic in the United States was caused by a novel strain of the Influenza A/H1N1 virus, commonly referred to as "swine flu", that was first detected on 15 April 2009. While the 2009 H1N1 virus strain was commonly referred to as "swine flu", there is no evidence that it is endemic to pigs or of transmission from pigs to people; instead, the virus spreads from person to person. On April 25, the World Health Organization declared a public health emergency, followed concurringly by the Obama administration on April 26.

<span class="mw-page-title-main">Pandemic H1N1/09 virus</span> Virus responsible for the 2009 swine flu pandemic

The pandemic H1N1/09 virus is a swine origin influenza A virus subtype H1N1 strain that was responsible for the 2009 swine flu pandemic. This strain is often called swine flu by the public media. For other names, see the Nomenclature section below.

<span class="mw-page-title-main">2009 swine flu pandemic vaccine</span> Protection against the H1N1/09 virus

The 2009 swine flu pandemic vaccines were influenza vaccines developed to protect against the pandemic H1N1/09 virus. These vaccines either contained inactivated (killed) influenza virus, or weakened live virus that could not cause influenza. The killed virus was injected, while the live virus was given as a nasal spray. Both these types of vaccine were produced by growing the virus in chicken eggs. Around three billion doses were produced, with delivery in November 2009.

In epidemiology, a non-pharmacological intervention (NPI) is any method used to reduce the spread of an epidemic disease without requiring pharmacological drug treatments. Examples of non-pharmacological interventions that reduce the spread of infectious diseases include wearing a face mask and staying away from sick people.

Type A influenza vaccine is for the prevention of infection of influenza A virus and also the influenza-related complications. Different monovalent type A influenza vaccines have been developed for different subtypes of influenza A virus including H1N1 and H5N1. Both intramuscular injection or intranasal spray are available on market. Unlike the seasonal influenza vaccines which are used annually, they are usually used during the outbreak of certain strand of subtypes of influenza A. Common adverse effects includes injection site reaction and local tenderness. Incidences of headache and myalgia were also reported with H1N1 whereas cases of fever has also been demonstrated with H5N1 vaccines. It is stated that immunosuppressant therapies would reduce the therapeutic effects of vaccines and that people with egg allergy should go for the egg-free preparations.

References

  1. 1 2 Carrat, Fabrice; Luong, Julie; Lao, Hervé; Sallé, Anne-Violaine; Lajaunie, Christian; Wackernagel, Hans (2006). "A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics". BMC Medicine. 4: 26. doi: 10.1186/1741-7015-4-26 . PMC   1626479 . PMID   17059593.
  2. Mitamura, Keiko; Sugaya, Norio (2006). "Diagnosis and Treatment of influenza". Uirusu. 56 (1): 109–16. doi: 10.2222/jsv.56.109 . PMID   17038819.
  3. Grassly, Nicholas C.; Fraser, Christophe (2008). "Mathematical models of infectious disease transmission". Nature Reviews Microbiology. 6 (6): 477–87. doi:10.1038/nrmicro1845. PMC   7097581 . PMID   18533288.
  4. 1 2 3 4 5 Weber, Thomas P.; Stilianakis, Nikolaos I. (2008). "Inactivation of influenza a viruses in the environment and modes of transmission: A critical review". Journal of Infection. 57 (5): 361–73. doi:10.1016/j.jinf.2008.08.013. PMC   7112701 . PMID   18848358.
  5. Hall, C. B. (2007). "The Spread of Influenza and Other Respiratory Viruses: Complexities and Conjectures". Clinical Infectious Diseases. 45 (3): 353–9. doi: 10.1086/519433 . PMC   7107900 . PMID   17599315.
  6. 1 2 3 4 5 6 Center for Disease Control and Prevention: "QUESTIONS & ANSWERS: Novel H1N1 Flu (Swine Flu) and You" Retrieved December 13, 2009
  7. Tellier, Raymond (2006). "Review of Aerosol Transmission of Influenza a Virus". Emerging Infectious Diseases. 12 (11): 1657–62. doi:10.3201/eid1211.060426. PMC   3372341 . PMID   17283614.
  8. Brankston, Gabrielle; Gitterman, Leah; Hirji, Zahir; Lemieux, Camille; Gardam, Michael (2007). "Transmission of influenza a in human beings". The Lancet Infectious Diseases. 7 (4): 257–65. doi:10.1016/S1473-3099(07)70029-4. PMID   17376383.
  9. Cole, Eugene C.; Cook, Carl E. (1998). "Characterization of infectious aerosols in health care facilities: An aid to effective engineering controls and preventive strategies". American Journal of Infection Control. 26 (4): 453–64. doi:10.1016/S0196-6553(98)70046-X. PMC   7132666 . PMID   9721404.
  10. Thomas, Y.; Vogel, G.; Wunderli, W.; Suter, P.; Witschi, M.; Koch, D.; Tapparel, C.; Kaiser, L. (2008). "Survival of Influenza Virus on Banknotes". Applied and Environmental Microbiology. 74 (10): 3002–7. Bibcode:2008ApEnM..74.3002T. doi:10.1128/AEM.00076-08. PMC   2394922 . PMID   18359825.
  11. "Influenza: Viral Infections: Merck Manual Home Edition". www.merck.com. Retrieved 2008-03-15.
  12. Bean, B.; Moore, B. M.; Sterner, B.; Peterson, L. R.; Gerding, D. N.; Balfour, H. H. (1982). "Survival of Influenza Viruses on Environmental Surfaces". Journal of Infectious Diseases. 146 (1): 47–51. doi:10.1093/infdis/146.1.47. PMID   6282993.
  13. 1 2 "Influenza Factsheet" (PDF). Center for Food Security and Public Health, Iowa State University. p. 7
  14. 1 2 3 World Health Organization: "What Can I Do?" Retrieved January 20, 2010
  15. 1 2 Yin, Xiuchen; Yin, Xin; Rao, Baizhong; Xie, Chunfang; Zhang, Pengchao; Qi, Xian; Wei, Ping; Liu, Huili (April 2014). "Antibodies against avian-like A (H1N1) swine influenza virus among swine farm residents in eastern China: Antibodies Against Avian Like H1N1 Swine Influenza Virus". Journal of Medical Virology. 86 (4): 592–596. doi:10.1002/jmv.23842. PMID   24497077. S2CID   20037718.
  16. 1 2 3 4 Aledort, Julia E; Lurie, Nicole; Wasserman, Jeffrey; Bozzette, Samuel A (2007). "Non-pharmaceutical public health interventions for pandemic influenza: An evaluation of the evidence base". BMC Public Health. 7: 208. doi: 10.1186/1471-2458-7-208 . PMC   2040158 . PMID   17697389.
  17. MacIntyre, C. Raina; Cauchemez, Simon; Dwyer, Dominic E.; Seale, Holly; Cheung, Pamela; Browne, Gary; Fasher, Michael; Wood, James; Gao, Zhanhai; Booy, Robert; Ferguson, Neil (2009). "Face Mask Use and Control of Respiratory Virus Transmission in Households". Emerging Infectious Diseases. 15 (2): 233–41. doi:10.3201/eid1502.081167. PMC   2662657 . PMID   19193267.
  18. Weinstein, R. A.; Bridges, C. B.; Kuehnert, M. J.; Hall, C. B. (2003). "Transmission of Influenza: Implications for Control in Health Care Settings". Clinical Infectious Diseases. 37 (8): 1094–101. doi: 10.1086/378292 . PMID   14523774.
  19. "Interim Guidance for the Use of Masks to Control Influenza Transmission". CDC. August 1, 2009.
  20. Murin, S.; Bilello, K. S. (2005). "Respiratory tract infections: Another reason not to smoke". Cleveland Clinic Journal of Medicine. 72 (10): 916–20. doi:10.3949/ccjm.72.10.916. PMID   16231688. S2CID   19183328.
  21. Kark, Jeremy D.; Lebiush, Moshe; Rannon, Lotte (1982). "Cigarette Smoking as a Risk Factor for Epidemic A(H1N1) Influenza in Young Men". New England Journal of Medicine. 307 (17): 1042–6. doi:10.1056/NEJM198210213071702. PMID   7121513.
  22. Finklea, J. F.; Sandifer, S. H.; Smith, D. D. (1969). "Cigarette smoking and epidemic influenza". American Journal of Epidemiology. 90 (5): 390–9. doi:10.1093/oxfordjournals.aje.a121084. PMID   5356947.
  23. Kark, J. D.; Lebiush, M (1981). "Smoking and epidemic influenza-like illness in female military recruits: A brief survey". American Journal of Public Health. 71 (5): 530–2. doi:10.2105/ajph.71.5.530. PMC   1619723 . PMID   7212144.
  24. Nicholson, K. G.; Kent, J; Hammersley, V (1999). "Influenza a among community-dwelling elderly persons in Leicestershire during winter 1993-4; cigarette smoking as a risk factor and the efficacy of influenza vaccination". Epidemiology and Infection. 123 (1): 103–8. doi:10.1017/s095026889900271x. JSTOR   4617449. PMC   2810733 . PMID   10487646.
  25. Weinstein, R. A.; Hota, B. (2004). "Contamination, Disinfection, and Cross-Colonization: Are Hospital Surfaces Reservoirs for Nosocomial Infection?". Clinical Infectious Diseases. 39 (8): 1182–9. doi: 10.1086/424667 . PMC   7107941 . PMID   15486843.
  26. 1 2 McDonnell, G; Russell, A. D. (1999). "Antiseptics and disinfectants: Activity, action, and resistance". Clinical Microbiology Reviews. 12 (1): 147–79. doi:10.1128/CMR.12.1.147. PMC   88911 . PMID   9880479.
  27. "Chlorine Bleach: Helping to Manage the Flu Risk". Water Quality & Health Council. April 2009. Retrieved 2009-05-12.
  28. Hatchett, R. J.; Mecher, C. E.; Lipsitch, M. (2007). "Public health interventions and epidemic intensity during the 1918 influenza pandemic". Proceedings of the National Academy of Sciences. 104 (18): 7582–7. Bibcode:2007PNAS..104.7582H. doi: 10.1073/pnas.0610941104 . PMC   1849867 . PMID   17416679.
  29. Bootsma, M. C. J.; Ferguson, N. M. (2007). "The effect of public health measures on the 1918 influenza pandemic in U.S. Cities". Proceedings of the National Academy of Sciences. 104 (18): 7588–93. Bibcode:2007PNAS..104.7588B. doi: 10.1073/pnas.0611071104 . PMC   1849868 . PMID   17416677.
  30. Gunaratnam, Praveena J; Tobin, Sean; Seale, Holly; Marich, Andrew; McAnulty, Jeremy (2014). "Airport arrivals screening during pandemic (H1N1) 2009 influenza in New South Wales, Australia". The Medical Journal of Australia. 200 (5): 290–2. doi: 10.5694/mja13.10832 . PMID   24641156.
  31. Nishiura, Hiroshi; Kamiya, Kazuko (2011). "Fever screening during the influenza (H1N1-2009) pandemic at Narita International Airport, Japan". BMC Infectious Diseases. 11: 111. doi: 10.1186/1471-2334-11-111 . PMC   3096599 . PMID   21539735.
  32. "Prevention Strategies for Seasonal Influenza in Healthcare Settings". CDC. October 5, 2016.
  33. "Safety and Health Topics | Seasonal Flu – Employer Guidance – Reducing Healthcare Workers' Exposures to Seasonal Flu Virus | Occupational Safety and Health Administration". www.osha.gov. Retrieved 2019-10-24.
  34. "CDC H1N1 Flu | Action Steps for Parents of Children at High Risk for Flu Complications".
  35. "Vaccination Against H1N1 to Become Universal". Pravda.ru. 2009-10-06. Retrieved 2009-10-06.
  36. Weston, Dale; Blackburn, Ruth; Potts, Henry W.W.; Hayward, Andrew C. (2017). "Predictors of self and parental vaccination decisions in England during the 2009 H1N1 pandemic: Analysis of the Flu Watch pandemic cohort data". Vaccine. 35 (31): 3875–3882. doi:10.1016/j.vaccine.2017.05.061. PMC   5593150 . PMID   28606815.
  37. "Survey Finds Just 40% of Adults "Absolutely Certain" They Will Get H1N1 Vaccine". October 2, 2009. Retrieved October 23, 2009.
  38. "Survey: Americans expect widespread swine flu ahead". USA Today. Atlanta, Georgia, USA. AP. 2009-07-16. Retrieved 2009-09-27.
  39. "Adverts promote swine flu service". BBC. 2009-07-24. Retrieved 2009-09-17.
  40. "Variant Influenza Viruses: Background and CDC Risk Assessment and Reporting | CDC". www.cdc.gov. 2018-10-09. Retrieved 2019-10-24.
  41. 1 2 Schoch-Spana, Monica; Bouri, Nidhi; Rambhia, Kunal J.; Norwood, Ann (September 2010). "Stigma, Health Disparities, and the 2009 H1N1 Influenza Pandemic: How to Protect Latino Farmworkers in Future Health Emergencies". Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. 8 (3): 243–254. doi:10.1089/bsp.2010.0021. ISSN   1538-7135. PMID   20825335.
  42. 1 2 3 Steege, Andrea L.; Baron, Sherry; Davis, Shelley; Torres-Kilgore, Judith; Sweeney, Marie Haring (October 2009). "Pandemic Influenza and Farmworkers: The Effects of Employment, Social, and Economic Factors". American Journal of Public Health. 99 (S2): S308–S315. doi:10.2105/ajph.2009.161091. ISSN   0090-0036. PMC   4504372 . PMID   19797742.
  43. Stewart, R. J.; Rossow, J.; Conover, J. T.; Lobelo, E. E.; Eckel, S.; Signs, K.; Stobierski, M. G.; Trock, S. C.; Fry, A. M.; Olsen, S. J.; Biggerstaff, M. (2017-11-16). "Do animal exhibitors support and follow recommendations to prevent transmission of variant influenza at agricultural fairs? A survey of animal exhibitor households after a variant influenza virus outbreak in Michigan". Zoonoses and Public Health. 65 (1): 195–201. doi:10.1111/zph.12425. ISSN   1863-1959. PMC   6631301 . PMID   29143461.